Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-25 @ 3:38 AM
NCT ID:
NCT00584402
Eligibility Criteria:
Inclusion Criteria:
* Patients with primary hepatocellular carcinoma (HCC) or secondary (metastatic) carcinoma of the liver who have been referred for ultrasound-guided radiofrequency ablation (RFA) treatment
* Recent (within 90 days) CT or MRI scan with report of one or more tumors ≤ 1.5 cm in diameter
* Patient is stable and is to be managed conservatively (i.e. non-surgically)
* 18 years of age or older
* Ability and willingness to provide written informed consent
Exclusion Criteria:
* Known or suspected cardiac shunt(s)
* Known sensitivity to octafluoropropane
* Pregnant or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00584402
Study Brief:
Protocol Section:
NCT00584402